GlassScriptPhysician profile
James B Williams
NPI 1982673521
$2,738.34
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $187 · 2021: $315 · 2022: $506 · 2023: $403 · 2024: $444 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $460.76 | 2020-2025 | Coroflow, Supera, Cardiomems |
| Pfizer INC. | $320.72 | 2019-2025 | |
| Boston Scientific Corporation | $294.70 | 2021-2025 | Watchman, Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $284.30 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $251.87 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $208.73 | 2021-2023 | Farxiga |
| Amgen INC. | $166.34 | 2020-2025 | Repatha, Repatha |
| Medtronic, INC. | $150.75 | 2021 | |
| Edwards Lifesciences Corporation | $148.46 | 2024 | |
| Merck Sharp & Dohme LLC | $103.79 | 2023-2024 | Winrevair, Verquvo |
| Shockwave Medical, INC | $101.19 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| United Therapeutics Corporation | $79.52 | 2025 | |
| Gilead Sciences, INC. | $36.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.91 | 2019 | |
| Celgene Corporation | $21.13 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.54 | 2019 | |
| Agepha Pharma Fz LLC | $19.10 | 2025 | Lodoco |
| Irhythm Technologies, INC. | $15.65 | 2024 | Zio Xt Patch |
| Cardiovascular Systems INC. | $14.54 | 2020 | |
| Portola Pharmaceuticals, LLC | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.